SC
ZBH icon

Savant Capital’s Zimmer Biomet ZBH Stock Holding History

Savant Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Buy
5,369
+1,398
+35% +$123K ﹤0.01% 1249
2026
Q1 		$359K Sell
3,971
-124
-3% -$11.4K ﹤0.01% 1084
2025
Q4 		$368K Sell
4,095
-193
-5% -$18.3K ﹤0.01% 958
2025
Q3 		$422K Buy
4,288
+247
+6% +$24.5K ﹤0.01% 865
2025
Q2 		$369K Buy
4,041
+59
+1% +$5.71K ﹤0.01% 872
2025
Q1 		$451K Buy
3,982
+205
+5% +$21.9K ﹤0.01% 700
2024
Q4 		$399K Sell
3,777
-910
-19% -$97.6K ﹤0.01% 975
2024
Q3 		$506K Buy
+4,687
New +$512K ﹤0.01% 864
2024
Q2 		– Sell
-6,785
Closed -$895K – 1350
2024
Q1 		$895K Buy
6,785
+4,804
+243% +$600K 0.01% 575
2023
Q4 		$241K Sell
1,981
-248
-11% -$27.7K ﹤0.01% 762
2023
Q3 		$250K Sell
2,229
-170
-7% -$21.6K ﹤0.01% 706
2023
Q2 		$349K Buy
2,399
+65
+3% +$8.83K 0.01% 606
2023
Q1 		$302K Buy
2,334
+214
+10% +$26.9K 0.01% 591
2022
Q4 		$270K Sell
2,120
-107
-5% -$12.4K 0.01% 491
2022
Q3 		$233K Buy
2,227
+24
+1% +$2.63K 0.01% 479
2022
Q2 		$231K Buy
2,203
+11
+0.5% +$1.3K 0.01% 493
2022
Q1 		$280K Buy
2,192
+427
+24% +$51.5K 0.01% 469
2021
Q4 		$218K Sell
1,765
-2
-0.1% -$262 0.01% 527
2021
Q3 		$251K Buy
1,767
+107
+6% +$15.7K 0.01% 455
2021
Q2 		$259K Buy
1,660
+44
+3% +$7.13K 0.01% 425
2021
Q1 		$251K Sell
1,616
-50
-3% -$7.75K 0.01% 401
2020
Q4 		$249K Sell
1,666
-82
-5% -$11.6K 0.01% 386
2020
Q3 		$231K Sell
1,748
-106
-6% -$13.8K 0.02% 358
2020
Q2 		$215K Sell
1,854
-561
-23% -$64.6K 0.02% 369
2020
Q1 		$237K Buy
2,415
+1,005
+71% +$132K 0.02% 334
2019
Q4 		$205K Buy
+1,410
New +$195K 0.03% 337
2015
Q4 		– Sell
-2,338
Closed -$213K – 228
2015
Q3 		$213K Buy
+2,338
New +$234K 0.08% 193

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Savant Capital's ZBH Position: Q2 2026 in Review

Savant Capital increased its Zimmer Biomet (ZBH) stake by 35% in Q2 2026, buying an estimated $123K and bringing the position to 5,369 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

Savant Capital first reported a position in ZBH in Q3 2015 and has held it in 27 quarters since. The position peaked at $895K in Q1 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Savant Capital held 5,369 shares of Zimmer Biomet worth $475K as of Q2 2026.
  • Savant Capital bought 1,398 Zimmer Biomet shares in Q2 2026, an estimated $123K.
  • Zimmer Biomet made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1249 holding.
  • Savant Capital first reported a position in Zimmer Biomet in Q3 2015 and has held it in 27 quarters since.
  • Savant Capital's Zimmer Biomet position peaked at $895K in Q1 2024.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.